This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Harris (HRS) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Continuous investments in technology and streak of contract wins from customers within the U.S. federal government are likely to aid Harris' (HRS) fiscal third-quarter results.
The Zacks Analyst Blog Highlights: Cigna, Ceridian, Estee Lauder, Arconic and Fortinet
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cigna, Ceridian, Estee Lauder, Arconic and Fortinet
4 High Earnings Yield Stocks to Strengthen Your Portfolio
by Zacks Equity Research
Earnings yield is handy for comparing the performance of the market with the 10-year Treasury yield.
What Awaits Frontier Communications (FTR) in Q1 Earnings?
by Zacks Equity Research
Frontier Communications (FTR) is well poised to benefit from its Consumer business, which is likely to result in an improved revenue trend in the first quarter.
What's in Store for Qualcomm (QCOM) This Earnings Season?
by Zacks Equity Research
For the fiscal second quarter, Qualcomm (QCOM) expects revenues in the range of $4.4-$5.2 billion. Non-GAAP earnings are projected in the range of 65-75 cents per share.
Is a Beat in Store for Cigna (CI) This Earnings Season?
by Zacks Equity Research
Cigna's (CI) Q1 earnings should benefit from increase in revenues and membership.
What's Awaits Prudential Financial (PRU) in Q1 Earnings?
by Zacks Equity Research
Prudential's (PRU) first-quarter results are likely to benefit from premium sales, greater scale, expanded product offerings and broader distribution capabilities.
5 Top Stocks to Buy Ahead of Earnings This Week
by Nalak Das
Last week, the market benchmark S&P 500 Index and tech-heavy Nasdaq Composite recorded new all-time highs.
Cigna (CI) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: CommScope, Incyte, Cigna, Columbia Sportswear and Synopsys
by Zacks Equity Research
The Zacks Analyst Blog Highlights: CommScope, Incyte, Cigna, Columbia Sportswear and Synopsys
5 Finance Sector Stocks Set to Beat Q1 Earnings Estimates
by Swayta Shah
Improving economy, higher rates and decent operating backdrop will likely support finance sector stocks in Q1 earnings.
Can S&P 500 and Nasdaq Sustain Record Run? 5 Top Picks
by Nalak Das
The broad-market S&P 500 Index and tech-laden Nasdaq Composite closed at an all-time high level yesterday.
Top 5 ROE Stocks to Buy on Better-Than-Expected Q1 Earnings
by Supriyo Bose
ROE helps investors distinguish profit-generating companies from profit burners and is useful in determining the financial health of a company.
Top Research Reports for Roche, Danaher & BlackRock
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Roche (RHHBY), Danaher (DHR) and BlackRock (BLK).
Stock Market News For Apr 18, 2019
by Zacks Equity Research
Wall Street closed lower on Wednesday as stiff loses of the healthcare sector negated the positive impact of strong first quarter earnings results.
Medicare-for-All, Mueller Report Spell Danger: 5 Utility Picks
by Swarup Gupta
Superior dividend yields and steady revenues make utilities good choices in tough times.
The Zacks Analyst Blog Highlights: Mastercard, Honeywell, Thermo Fisher, Cigna and Norfolk Southern
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Mastercard, Honeywell, Thermo Fisher, Cigna and Norfolk Southern
Top Analyst Reports for Mastercard, Honeywell & Thermo Fisher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), Honeywell (HON) and Thermo Fisher (TMO).
Cigna, Express Scripts Join Amazon Alexa for New Voice Skills
by Zacks Equity Research
Cigna (CI) and Express Scripts team up with Amazon Alexa to launch voice skills for enriching their customers' healthcare experience.
Aging Demography, Consolidation Brighten HMO Industry Outlook
by Sapna Bagaria
Increasing retirement population, industry consolidation, growth of ancillary business and easing of regulatory changes promise solid growth for the HMO industry.
Cigna (CI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $166.46, marking a -1.83% move from the previous day.
BioDelivery (BDSI) Q4 Earnings In Line, Sales Beat, Stock Up
by Zacks Equity Research
BioDelivery Sciences (BDSI) reports in-line loss in Q4. Sales beat the consensus mark. The company issues encouraging guidance for 2019.
Assured Guaranty (AGO) Q4 Earnings Up Y/Y on Lower Expenses
by Zacks Equity Research
Assured Guaranty (AGO) fourth quarter results reflect higher net investment income, reduction in expenses and lower tax rate in the quarter.
Kemper (KMPR) Stock Rallies 38% in a Year's Time: Here's Why
by Zacks Equity Research
Kemper's (KMPR) operational excellence should help the stock continue the bull run.
AIG Surges: Stock Moves 5.3% Higher
by Zacks Equity Research
AIG saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.